Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade

Panayiotis Anastasiou(The Francis Crick Institute), Julian Downward(The Francis Crick Institute)
Nature Communications
September 25, 2024
Cited by 19


Related Papers